Zdrowie i gospodarka · 03/08/2023
FDA Announces Draft Guidance on Waivers for HIV Antiretroviral Drugs
The FDA is releasing a draft guidance on when companies can get waivers, reductions, or refunds for certain HIV treatments under the Prescription Drug User Fee Act (PDUFA).
Source: Federal Register — Food and Drug AdministrationOpen original release →